B Braun Heparin Recall Lawyer Class Action Lawsuit Attorney Information

Scientific Protein Laboratories LLC (SPL) manufactures Heparin Sodium USP active pharmaceutical ingredient that is used by B. Braun Medical Inc. to produce Heparin Sodium in 5% Dextrose and 0.9% Sodium Chloride injection solution
Click Here To Contact Us For A FreeCase Evaluation
nationwide recall of Heparin Sodium USP active pharmaceutical ingredient (API). The recall affects the following 23 Finished Product (FP) lots manufactured and distributed by B. Braun Medical Inc. nationwide and to Canada.
B. Braun FP Lot # B. Braun FP Material Description NDC Numbers CAN DIN
J7D490 P5872 Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) 0264-9587-20 N/A
J7C684 P5771 Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) 0264-9577-10 N/A
J7D496 P5771 Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) 0264-9577-10 N/A
J7C470 P5872 Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) 0264-9587-20 N/A
J7D580 P5671-00 Heparin Sodium 20,000 Units in 5% Dextrose Injection (500mL) N/A 02209713
J7E420 P5872-00 Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) N/A 02209721
J7C611 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
J7C557 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
J7C477 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
J7C705 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
J7D485 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
J7E415 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
J7E416 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
J7E494 P5872 Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) 0264-9587-20 N/A
J7E500 P5771 Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) 0264-9577-10 N/A
J7E577 P5771-00 Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) N/A 01935941
J7E489 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
J7N556 P5872 Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) 0264-9587-20 N/A
J7P404 P5771 Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) 0264-9577-10 N/A
J7N604 P5771 Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) 0264-9577-10 N/A
J7P476 P5872 Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) 0264-9587-20 N/A
J7N519 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
J7N676 P8721 Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) 0264-9872-10 01935933
Click Here To Contact Us For A FreeCase Evaluation
B. Braun Medical Inc. began recalling the lots on March 21, 2008. This product recall was initiated due to a notification received from the supplier, Scientific Protein Laboratories (SPL), disclosing that one lot of Heparin Sodium, USP Active Pharmaceutical Ingredient acquired by B. Braun Medical Inc. has a heparin-like contaminant.
Click Here To Contact Us For A FreeCase Evaluation
The Food and Drug Administration has received reports of serious injuries and/or deaths in patients who have been administered Heparin injectable products of other companies containing this contaminant. As indicated in the notification issued by the supplier SPL, typical symptoms include anaphylactic-like reactions such as low blood pressure, shortness of breath, nausea, vomiting, diarrhea and abdominal pain.
Heparin Lawyer Class Action Lawsuit Attorney Website